Regulatory effects of HDL on smooth muscle cell prostacyclin release

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 19, Issue 10, 1999, Pages 2405-2411

  Viñals, Marisa ^a   Martínez González, José ^a   Badimon, Lina ^a,b  

^a Institut Català de Ciències Cardiovasculars   (Spain)

^b HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

Cyclooxygenase 1; Cyclooxygenase 2; Cytosolic phospholipase A2; Lipoproteins; Mitogen activated protein kinases

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; ACETYLSALICYLIC ACID; ARACHIDONIC ACID; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DEXAMETHASONE; HIGH DENSITY LIPOPROTEIN; ISOPROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PROSTACYCLIN; PROTEIN KINASE C;

ANIMAL CELL; AORTA MEDIA; ARTICLE; CELL PROTECTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FATTY ACID TRANSPORT; LIPID ANALYSIS; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RABBIT; REGULATORY MECHANISM; SMOOTH MUSCLE FIBER;

EID: 17744410461     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.19.10.2405     Document Type: Article

References (68)

1. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. High density lipoproteins as a protective factor against coronary heart disease: the Framingham study. Am J Med. 1977;62:707-714.
2. Rhoads GG, Gulbrandse CL, Kagen A. Serum lipoprotein and coronary heart disease in a population study of Hawaii Japanese men. N Engl J Med. 1977;294:293-298.
3. Barter P, Rye K. High density lipoproteins and coronary heart disease. Atherosclerosis. 1996;121:1-12.
4. Badimon JJ, Badimon L, Galvez A, Dische R, Fuster V. High density lipoprotein plasma fraction inhibits aortic fatty streaks in cholesterol-fed rabbits. J Lab Invest. 1989;60:455-461.
5. Badimon JJ, Badimon L, Fuster V. Regression of atherosclerosis lesions by high density plasma fraction in the cholesterol-fed rabbit. J Clin Invest. 1990;85:1234-1241.
6. Oram JF, Albers JJ, Cheung MC, Bierman EL. The effects of subfractions of high density lipoprotein on cholesterol efflux from cultured fibroblasts. J Biol Chem. 1981;256:8348-8356.
7. Oram JF. The effects of high density lipoprotein subfractions on cholesterol homeostasis in human fibroblasts and arterial smooth muscle cells. Arteriosclerosis. 1983;3:420-432.
8. 2 (prostacyclin) by cultured human and bovine endothelial cells. Proc Natl Acad Sci U S A. 1977;74:3922-3926.
9. Baezinger NL, Becherer PR, Majerus PW. Characterization of prostacyclin synthesis in cultured human arterial smooth muscle cells, venous endothelial cells and skin fibroblasts. Cell. 1979;16:967-974.
10. 2 synthesis. J Lipid Res. 1985;26: 1269-1276.
11. Fleisher LN, Tall AR, Witte LD, Miller RW, Cannon PJ. Stimulation of arterial endothelial cell prostacyclin synthesis by high density lipoproteins. J Biol Chem. 1982;257:6653-6655.
12. 2 synthesis by plasma high and low density lipoproteins. Circ Res. 1984;54:554-565.
13. Shakhov Y, Larrue J, Perova N, Doria B, Daret D, Shcherbakova I, Bricaud H, Oganov R. Prostacyclin-mediated effect of high density lipoproteins as cellular cholesterol acceptors on aortic smooth muscle cells. J Mol Cell Cardiol. 1989;21:461-468.
14. 2) in arteries. Artery. 1980;7:488-495.
15. 2 formation by isolated aortic preparations of rabbits. Prostaglandins Leukot Med. 1986;22:221-234.
16. Zhang H, Davis WB, Ghem X, Jones KH, Whisler RL, Cornwell DG. Effects of oxidized low density lipoproteins on arachidonic acid metabolism in smooth muscle cells. J Lipid Res. 1990;31:551-565.
17. Ek B, Humble L. Correlation between oxidation of low density lipoproteins and prostacyclin synthesis in cultured smooth muscle cells. Biochem Pharmacol. 1991;41:695-699.
18. Moncada S, Vane JR. Arachidonic acid metabolites and the interactions between platelets and blood-vessel walls. N Engl J Med. 1979;300: 1142-1147.
19. 2) by layers of the arterial wall: an explanation for the anti-thrombotic properties of vascular endothelium. Thromb Res. 1977;11:323-344.
20. Thiemermann C. Biosynthesis and interaction of endothelium-derived vasoactive mediators. Eicosanoids. 1991;4:187-202.
21. Smith WL, Garavito RM, DeWitt DL. Prostaglandin endoperoxide H synthase (cyclooxygenases) 1 and 2. J Biol Chem. 1996;271: 33157-33160.
22. DeWitt DL. Prostaglandin endoperoxide synthase: regulation of enzyme expression. Biochim Biophys Acta. 1991;1083:121-134.
23. Pilbeam CC, Kawaguchi H, Hakeda Y, Voznesensky O, Alander CB, Raisz LG. Differential regulation of inducible and constitutive prostaglandin endoperoxide synthase in osteoblastic MC3T3-E1 cells. J Biol Chem. 1993;268:25643-25649.
24. Hla T, Neilson K. Human cyclooxygenase-2 cDNA. Proc Natl Acad Sci U S A. 1992;89:7384-7388.
25. Xie W, Chipman JG, Robertson DL, Erikson RL, Simmons DL. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc Natl Acad Sci U S A. 1991;88:2692-2696.
26. Pritchard KA, O'Banion MK, Miano JM, Vlasic N, Bhatia VG, Young DA, Stemerman MB. Induction of cyclooxigenase-2 in rat vascular smooth muscle cells in vitro and in vivo. J Biol Chem. 1994;269: 8504-8509.
27. Viñals M, Martínez-González J, Badimon JJ, Badimon L. HDL-induced prostacyclin release in smooth muscle cells is dependent on cyclooxygenase-2 (Cox-2). Arterioscler Thromb Vasc Biol. 1997;17:3481-3488.
28. 2. J Biol Chem. 1994;269:13057-13060.
29. Martínez-González, J, Viñals M, Vidal F, Llorente V, Badimon L. Mevalonate deprivation impairs IGF-I/insulin signaling in human vascular smooth muscle cells. Atherosclerosis. 1997;135:213-223.
30. Meade EA, Smith WL, DeWitt DL. Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs. J Biol Chem. 1993;268: 6610-6614.
31. Vidal F, Colomé C, Martínez-González J, Badimon L. Atherogenic concentrations of native low-density lipoproteins down-regulate nitric-oxide-synthase mRNA and protein levels in endothelial cells. Eur J Biochem. 1998;252:378-384.
32. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. New York, NY: Cold Spring Harbor Laboratory Press; 1989.
33. Gerlach WL, Bedbrook JR. Cloning and characterization of ribosomal RNA genes from wheat and barley. Nucleic Acids Res. 1979;7: 1869-1885.
34. Raz A, Wyche A, Needleman P. Temporal and pharmacological division of fibroblast cyclooxygenase expression into transcriptional and translational phases. Proc Natl Acad Sci U S A. 1989;86:1657-1661.
35. O'Banion MK, Sadowski HB, Winn V, Young DA. A serum- and glucocorticoid-regulated 4 kilobase mRNA encodes a cyclooxygenase-related protein. J Biol Chem. 1991;266:23261-23267.
36. 2+-independent phospholipase A2 by methyl arachidonyl fluorophosphonate. Biochim Biophys Acta. 1996;1302:55-60.
37. Reddy ST, Herschman HR. Prostaglandin synthase-1 and prostaglandin synthase-2 are coupled to distinct phospholipases for the generation of prostaglandin D2 in activated mast cells. J Biol Chem. 1997;272: 3231-3237.
38. Dudley DT, Pang L, Decker SJ, Bridges AJ, Saltiel AR. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc Natl Acad Sci U S A. 1995;92:7686-7689.
39. Alessi DR, Cuenda A, Cohen P, Dudley DT, Saltiel AR. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J Biol Chem. 1995;270:27489-27494.
40. Toullec D, Pianetti P, Coste H, Bellevergue P, Grand-Perret T, Ajakane M, Baudet V, Boisin P, Boursier E, Loriolle F, Duhamel L, Charon D, Kirilovsky J. The bisindolylmaleimide GF 109203 is a potent and selective inhibitor of protein kinase C. J Biol Chem. 1991;266: 15771-15781.
41. Roshak A, Sathe G, Marshall A. Suppression of monocyte 85-kDa phospholipase A2 by antisense and effects on endotoxin-induced prostaglandin biosynthesis. J Biol Chem. 1994;269:25999-26005.
42. 2. Arthritis Rheum. 1994;37:653-661.
43. 2 phosphorylation. Biochem Pharmacol. 1996;52:351-356.
44. Dinarello CA. The interleukin-1 family: 10 years of discovery. FASEB J. 1994;8:1314-1325.
45. Simonson MS, Wolfe JA, Konieczkowski M, Sedor JR, Dunn MJ. Regulation of prostaglandin endoperoxide synthase gene expression in cultured rat mesangial cells: induction by serum via a protein kinase-C-dependent mechanism. Mol Endocrinol. 1991;5:441-451.
46. Kujubu DA, Herschman HR. Dexamethasone inhibits mitogen induction of the TIS10 prostaglandin synthase/cyclooxygenase gene. J Biol Chem. 1992;267:7991-7994.
47. Sa G, Murugesan G, Jaye M, Ivashchenko Y, Fox PL. Activation of cytosolic phospholipase A2 by basic fibroblast growth factor via a p42 mitogen-activated protein kinase-dependent phosphorylation pathway in endothelial cells. J Biol Chem. 1995;270:2360-2366.
48. Graves LM, Bornfeldt KE, Sidhu JS, Argast GM, Raines EW, Ross R, Leslie CC, Krebs EG. Platelet-derived growth factor stimulates protein kinase A through a mitogen-activated protein kinase-dependent pathway in human arterial smooth muscle cells. J Biol Chem. 1996;271:505-511.
49. 2 by platelet-derived growth factor is essential for cyclooxygenase-2-dependent prostaglandin E2 synthesis in mouse osteoblasts cultured with interleukin-1. J Biol Chem. 1997;272:5952-5958.
50. Brawerman G. mRNA degradation in eukaryotic cells: an overview. In: Belasco JG, Brawerman G, eds. Control of Messenger RNA Stability. San Diego: Academic Press; 1991:149-159.
51. Tazawa R, Xu XM, Wu KK, Wang LH. Characterization of the genomic structure chromosomal location and promoter of human prostaglandin H synthase-2 gene. Biochem Biophys Res Commun. 1994;203:190-199.
52. Mendez AJ, Oram JF, Bierman E. Protein kinase C as a mediator of high density lipoprotein receptor-dependent efflux of intracellular cholesterol. J Biol Chem. 1991;266:10104-10111.
53. 3 stimulates multiple signaling pathways in human skin fibroblast. Arterioscler Thromb Vasc Biol. 1995;15:1975-1986.
54. Deeg MA, Bowen RF, Oram JF, Bierman EL. High density lipoproteins stimulate mitogen-activated protein kinases in human skin fibroblasts. Arterioscler Thromb Vasc Biol. 1997;17:1667-1674.
55. Zembowicz A, Jones SL, Wu KK. Induction of cyclooxygenase-2 in human umbilical vein endothelial cells by lysophosphatidylcholine. J Clin Invest. 1995;96:1688-1692.
56. Hordijk PL, Verlaan I, van Corven EJ, Moolenaar WH. Protein tyrosine phosphorylation induced by lysophosphatidic acid in rat-1 fibroblasts. J Biol Chem. 1994;269:645-651.
57. 2 to the nuclear envelope in acetylcholine-induced prostacyclin synthesis in rabbit coronary endothelial cells. Mol Phamacol. 1996;50:1139-1147.
58. Patel V, Brown C, Goodwin A, Wilkie N, Boarder MR. Phosphorylation and activation of p42 and p44 mitogen-activated protein kinase are required for the P2 purinoceptor stimulation of endothelial prostacyclin production. Biochem J. 1996;320:221-226.
59. 2 biosynthesis stimulated by interleukin-1β. J Biol Chem. 1997;272: 8083-8089.
60. Nishida E, Gotoh Y. The MAP kinase cascade is essential for diverse signal transduction pathways. Trends Biochem Sci. 1993;18:128-131.
61. Blumer KJ, Johnson GL. Diversity in function and regulation of MAP kinase pathways. Trends Biochem Sci. 1994;19:236-240.
62. Monaco L, Bond HM, Howell KE, Cortese R. A recombinant apoA-I-protein A hybrid reproduces the binding parameters of HDL to its receptor. EMBO J. 1987;6:3253-3260.
63. Barbaras R, Collet X, Chap H, Perret B. Specific binding of free apolipoprotein A-I to a high-affinity binding site on HepG2 cells: characterization of two high-density lipoprotein sites. Biochemistry. 1994;33: 2335-2340.
64. Thiemerman C, Mitchell JA, Ferns GAA. Eicosanoids and atherosclerosis. Curr Opin Lipidol. 1993;4:401-406.
65. Pomerantz KB, Nicholson AC, Hajjar DP. Signal transduction in atherosclerosis: second messengers and regulation of cellular cholesterol trafficking. In: Longenecker JB, et al, eds. Nutrition and Biotechnology in Heart Disease and Cancer. New York, NY: Plenum Press; 1995:49-64.
66. Morishita H, Yui Y, Hattori R, Aoyama T, Kawai C. Increased hydrolysis of cholesteryl ester with prostacyclin is potentiated by high density lipoprotein through the prostacyclin stabilization. J Clin Invest. 1990;86: 1885-1891.
67. Eldor A, Falcone DJ, Hajjar DP, Minick CR, Weksler BB. Recovery of prostacyclin production by de-endothelialized rabbit aorta. J Clin Invest. 1981;67:735-741.
68. Zoldhelyi P, McNatt J, Xu XM, Loose-Mitchell D, Meidell RS, Clubb FJ, Buja M, Willerson JT, Wu KK. Prevention of arterial thrombosis by adenovirus-mediated transfer of cyclooxygenase gene. Circulation. 1996;93:10-17.